Zeria Pharmaceutical Co., Ltd.
[Zeria Pharmaceutical Co., Ltd.] Notice of Appointment of Director Candidates | May 2026
Zeria Pharmaceutical Co., Ltd. plans to appoint director candidates at the shareholders' meeting scheduled for June 2026. New appointee includes Ms. Satomi Kojisato.
Key Figures
- Number of director candidates: 6 (including 1 new appointee)
- Brief biography of the new candidate: Joined the Ministry of Agriculture, Forestry and Fisheries in 2006, became CEO in 2022
- Scheduled shareholders' meeting date: June 26, 2026
AI要約
Overview of Executive Personnel Changes
Zeria Pharmaceutical Co., Ltd. has decided on the director candidates to be presented at the shareholders' meeting held on May 8, 2026, at the Board of Directors meeting. The candidates include current Chairman and CEO Yukihide Ibe, President and COO Mitsuhiro Ibe, as well as outside directors and new outside director candidates. The new candidate, Ms. Satomi Kojisato, has experience with the Ministry of Agriculture, Forestry and Fisheries and the University of Tokyo, and has been serving as CEO of HERS M&S since 2022.
Future Outlook and Corporate Strategy
This executive personnel change aims to strengthen the company's management structure and promote diversity. The new candidate, Ms. Kojisato, is expected to bring new perspectives to the company's business strategy by leveraging her experience in medical and environmental fields. Zeria Pharmaceutical Co., Ltd. will continue to focus on innovative drug development and business expansion, with a policy of strengthening its management team.
Zeria Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
